FLALGO

Main information

  • Trade name:
  • FLALGO Medicated plaster 140MG
  • Dosage:
  • 140MG
  • Pharmaceutical form:
  • Medicated plaster
  • Administration route:
  • Cutaneous use
  • Units in package:
  • 7 Sachet
  • Prescription type:
  • OTC medicinal products
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FLALGO Medicated plaster 140MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • DICLOFENAC
  • Product summary:
  • FLALGO

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • B - medicinal product after change, may be placed on the market
  • Authorization number:
  • 29/ 402/16-C
  • Last update:
  • 04-04-2018

11-7-2018

MyNicNaxs, LLC Issues Voluntary Nationwide Recall of Various Dietary Supplements Due to Undeclared Active Pharmaceutical Ingredient (API)

MyNicNaxs, LLC Issues Voluntary Nationwide Recall of Various Dietary Supplements Due to Undeclared Active Pharmaceutical Ingredient (API)

MyNicNaxs, LLC, Deltona, FL is voluntarily recalling all lots of dietary supplements distributed nationwide to the consumer level. The products have been found to contain undeclared active pharmaceutical ingredients (API). The presence of Sildenafil, Sibutramine, Diclofenac and/or Phenolphthalein in the dietary supplements renders it an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall. These products were distributed from January 2013, to December ...

FDA - U.S. Food and Drug Administration

There are no news related to this product.